Recordati Ireland

Company snapshot

Recordati Ireland was established in 2002 and is based in Ringaskiddy, Co. Cork, Ireland. It is part of the Recordati group, an international pharmaceutical company listed on the Italian Stock Exchange with a total staff of more than 4,300, dedicated to the research, development, manufacturing and marketing of value-adding medicines that improve quality of life and help people to enjoy longer, hea

• 4 active pipeline program(s) linked via ClinicalTrials.gov.
• 4 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Recordati Ireland. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Recordati Ireland.

1. Jun 8, 2026 Clinical update

   SOM230-RECAG-CL-0576 — Phase 2

2. Jun 8, 2026 Clinical update

   SOM230-RECAG-PK-612 — Phase 1

3. Jun 8, 2026 Clinical update

   SOM230-RECAG-PK-0605 — Phase 1

4. Jun 8, 2026 Clinical update

   CLCI699C2203 — Phase 2

View all clinical trial activity →

• What is Recordati Ireland?

  Recordati Ireland is a pharma organization headquartered in Cork, IE. Primary therapeutic focus areas include Post-bariatric hypoglycaemia, Cushing's disease, Post-Bariatric Hypoglycaemia. NovaPharmaNews links 4 clinical program(s), 0 drug profile(s), and 0 patent record(s) to th

• Is Recordati Ireland publicly traded?

  Recordati Ireland appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Recordati Ireland develop or market?

  We link 11 drug profile(s) where Recordati Ireland is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/recordati-ireland#company-drugs.

• What are the latest developments for Recordati Ireland?

  In the last 12 months our linked public records show 4 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Recordati Ireland focus on?

  Recordati Ireland focuses on Post-bariatric hypoglycaemia, Cushing's disease, Post-Bariatric Hypoglycaemia based on our analysis of their pipeline programs and drug development activities.